Biotechnology company Lipella Pharmaceuticals Inc. files for Chapter 11 bankruptcy months after facing Nasdaq delisting.
In connection with the Chapter 11 cases, the Company expects to seek customary “first-day” relief that, if approved by the Court, would allow it to continue day-to-day operations, including ...
Finch Therapeutics Group, Inc., a biotechnology company from Boston, enters bankruptcy along with three affiliates.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results